Faisal Al-Akayleh | Pharmacology | Excellence in Innovation

Prof. Faisal Al-Akayleh | Pharmacology | Excellence in Innovation

Professor Faisal Al-Akayleh, an editorial board member of the Jordan Journal of Pharmaceutical Sciences.  university of Petra, Jordan

🌟 Professor Faisal T. Al-Akayleh, Ph.D. is a distinguished expert in pharmaceutics and pharmaceutical technology, serving as the Head of the Department of Pharmaceutics and Pharmaceutical Technology at the University of Petra, Amman, Jordan. With a robust academic and professional background, Professor Al-Akayleh has made remarkable contributions as a pharmaceutical researcher, inventor, and consultant. He has authored five patents in the fields of nanotechnology, pharmaceutical science, and environmental applications. His innovative spirit is reflected in his leadership roles and impactful projects in drug delivery and nanotechnology. πŸ’ŠπŸ”¬

Publication Profile

Education

πŸŽ“ Ph.D. in Pharmaceutics and Pharmaceutical Technology – Professor Al-Akayleh’s academic journey is marked by his expertise in pharmaceutics, enabling him to advance the pharmaceutical industry with groundbreaking innovations. His education laid the foundation for his significant contributions to pharmaceutical technology and material science. πŸ“š

Experience

πŸ“ˆ With years of experience in academia and the pharmaceutical industry, Professor Al-Akayleh has served as a technical manager and consultant for various pharmaceutical companies. As an associate professor, he has led groundbreaking research projects and collaborated on numerous industry-funded initiatives. His leadership extends to his roles as a board member of the Jordan Journal of Pharmaceutical Sciences and the University of Petra Pharmaceutical Center. He also chairs the Ethical Approval Committee at the University of Petra. πŸ§ͺ

Awards and Honors

πŸ† Professor Al-Akayleh received the prestigious El Hassan Bin Talal Award for Scientific Excellence (2018) for his collaborative project on developing an oral insulin delivery system. His dedication to innovation has garnered recognition for advancing pharmaceutical research and development. ✨

Research Focus

πŸ” Professor Al-Akayleh specializes in drug delivery systems, nanotechnology, pharmaceutical material science, and environmental sustainability. His research addresses critical challenges in developing innovative drug formulations, including nanoparticles for improved skin permeation and novel excipients for enhanced drug delivery. 🌐

Conclusion

Professor Faisal T. Al-Akayleh is a trailblazer in pharmaceutical sciences, combining academic excellence with industrial expertise to deliver innovative solutions. His commitment to advancing pharmaceutics and nanotechnology continues to inspire scientific progress and foster meaningful collaborations. 🌟

Publications

Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals (2024)
Published in Pharmaceuticals, cited by 10 articles.

Novel therapeutic deep eutectic system for the enhancement of ketoconazole antifungal activity and transdermal permeability (2024)
Published in Journal of Molecular Liquids, cited by 15 articles.

AI-Driven Physical Rehabilitation Strategies in Post-Cancer Care (2024)
Presented at IEEE ICCR 2024 Conference, cited by 5 articles.

What We Know About the Actual Role of Traditional Probiotics in Health and Disease (2024)
Published in Probiotics and Antimicrobial Proteins, cited by 12 articles.

Utilizing olive leaves biomass as an efficient adsorbent for ciprofloxacin removal (2024)
Published in Environmental Monitoring and Assessment, cited by 8 articles.

Surapon Nochaiwong | Pharmacoepidemiology | Best Researcher Award

Mr.Surapon Nochaiwong | Pharmacoepidemiology | Best Researcher Award

 

πŸ‘¨β€πŸ« 🌾🌟Mr. Surapon Nochaiwong, a distinguished figure in pharmacoepidemiology and clinical epidemiology, serves as an academic staff member in the Department of Pharmaceutical Care at Chiang Mai University, Thailand. πŸŽ“ Holding a Doctor of Pharmacy (Pharm.D.) degree, he is also the founding Vice Head of the Pharmacoepidemiology and Statistics Research Center (PESRC) at the Faculty of Pharmacy.Nochaiwong’s educational journey includes a Pharm.D. from Chiang Mai University, a General Residency in Pharmacotherapy, and diplomas in Clinical Statistics and Clinical Epidemiology. His commitment to education and research makes him a respected figure in the academic and scientific community. πŸ”¬πŸŽ“

 

🌐 Professional Profiles

Affiliation/Community πŸ›οΈ

Pharmacoepidemiology and Statistics Research Center (PESRC) Faculty of Pharmacy, Chiang Mai University 50200 Department of Pharmaceutical Care Faculty of Pharmacy, Chiang Mai University 50200

Personal Statement 🌟

Surapon Nochaiwong earned his Doctor of Pharmacy (Pharm.D.) degree from Chiang Mai University, Thailand. Currently holding an academic position in the Department of Pharmaceutical Care, Faculty of Pharmacy, he is also the founding Vice Head of the Pharmacoepidemiology and Statistics Research Center (PESRC) at Chiang Mai University.

Since joining the Faculty of Pharmacy in 2012, Nochaiwong has actively contributed as a young scientist and principal investigator on over 10 extramurally funded local and national grants. He has an impressive publication record with more than 50 manuscripts and conference abstracts, accumulating over 800 citations in the international scientific community. His research interests span clinical epidemiology, pharmacoepidemiology, patient-reported outcomes in dialysis patients, and systematic review & evidence-based synthesis in nephrology and dermatology.

Areas of Expertise/Knowledge 🧠

Clinical Epidemiology, Pharmacoepidemiology, Dialysis, Chronic Pruritus, Patient-Reported Outcomes, Systematic Review and Knowledge Synthesis, Mental Health and COVID-19

Positions and Honors πŸ†

2021 – Present: Co-principal investigator, Government of Canada, the Canadian Institutes of Health Research (CIHR) Operating Grant: Emerging COVID-19 Research Gaps & Priorities, 2020 – Present: Principal investigator and head of the HOME-COVID-19 consortium, 2016 – Present: Head of the Pharmacoepidemiology and Statistics Research Center (PESRC), 2017 – Present: Head of the Thai Renal Outcomes Research (THOR) Investigators, 2019 – Present: Vice head of the Evidence-Based Synthesis in Dermatology (EBSD), 2015 – 2017: Co-principal investigator, Funded by Health Systems Research Institute of Thailand (HSRI) through National Research Council of Thailand (NRCT), 2013 – 2014: Principal investigator, Young Researcher Granted by Chiang Mai University

Education πŸ“š

Doctor of Pharmacy (Pharm.D.), Faculty of Pharmacy, Chiang Mai University, Thailand, General Residency in Pharmacotherapy, The College of Pharmacotherapy of Thailand, Thailand,  Diploma in Clinical Statistics, Faculty of Medicine, Chiang Mai University, Thailand Diploma in Clinical Epidemiology, Faculty of Medicine, Chiang Mai University, Thailand

Work Experience πŸ‘¨β€πŸ’Ό

2012-Present: Faculty of Pharmacy, Chiang Mai University, Thailand This detailed information provides a comprehensive overview of Surapon Nochaiwong’s academic and research journey, along with his significant contributions and affiliations in the field of pharmacy and healthcare.

πŸ“šTop Noted Publication

Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Clinical Outcomes, Patient-Reported Outcomes, and Economic Burden for Thai People Living with Chronic Urticaria (CORE-CU) in routine practice: A study protocol for a monocentric prospective longitudinal study

Transcultural adaptation and psychometric validation of the Thai-Brief Resilient Coping Scale: a cross-sectional study during the coronavirus disease 2019 pandemic in Thailand

Service-level barriers to and facilitators of access to services for the treatment of alcohol use disorder and problematic alcohol use: protocol for a scoping review

Psychological Resilience and Adverse Mental Health Issues in the Thai Population during the Coronavirus Disease 2019 Pandemic

Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives

Pharmacological interventions for hidradenitis suppurativa: a protocol for systematic review and network meta-analysis of randomised trials and non-randomised studies

Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study

Disparities and Factors Associated with Coronavirus Disease-2019-Related Public Stigma: A Cross-Sectional Study in Thailand

Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis